Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$90.63 - $120.22 $13.7 Million - $18.1 Million
-150,875 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$88.4 - $105.34 $4.9 Million - $5.84 Million
-55,430 Reduced 26.87%
150,875 $13.9 Million
Q4 2017

Feb 14, 2018

SELL
$84.48 - $104.02 $8,448 - $10,402
-100 Reduced 0.05%
206,305 $19.3 Million
Q3 2017

Nov 14, 2017

BUY
$73.17 - $103.47 $15.1 Million - $21.4 Million
206,405
206,405 $21 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.58B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.